MicroRNA‐21 Expression is regulated by β‐catenin/STAT3 Pathway and Promotes Glioma Cell Invasion by Direct Targeting RECK

MicroRNA‐21 (miR‐21) expression is increased in many types of human malignancy, including glioma. Recent studies report that miR‐21 regulates cell invasion by targeting RECK, however, the underlying transcriptional regulation of miR‐21 in glioma cells remains elusive.

[1]  C. Miracco,et al.  β-catenin and Gli1 are prognostic markers in glioblastoma , 2011, Cancer biology & therapy.

[2]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[3]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[4]  C. Kang,et al.  AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion. , 2010, Oncology reports.

[5]  Y. Kondo,et al.  The Modulation of MicroRNAs by Type I IFN through the Activation of Signal Transducers and Activators of Transcription 3 in Human Glioma , 2009, Molecular Cancer Research.

[6]  M. von Knebel Doeberitz,et al.  Wnt/β‐catenin‐pathway as a molecular target for future anti‐cancer therapeutics , 2005 .

[7]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[8]  T. Jiang,et al.  Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells , 2010, Brain Research.

[9]  Jörg Hackermüller,et al.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. , 2007, Blood.

[10]  Lei Han,et al.  MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol , 2010, BMC Cancer.

[11]  Lei Shi,et al.  Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. , 2010, Oncology reports.

[12]  Kai Stühler,et al.  Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas , 2010, Brain pathology.

[13]  H. Jiang,et al.  Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth , 2009, Cancer Gene Therapy.

[14]  T. Karn,et al.  Oncogenic alterations in primary human lung-tumors (review). , 1994, Oncology reports.

[15]  Wei Liu,et al.  MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. , 2008, Cancer letters.

[16]  M. Chaudhry,et al.  Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. , 2010, DNA and cell biology.

[17]  L. Pfeffer,et al.  Cancer esearch apeutics , Targets , and Chemical Biology Induces miR-21 through a Signal Transducer and ivator of Transcription 3 – Dependent Pathway as a R pressive Negative Feedback on IFN-Induced Apoptosis , 2010 .

[18]  H. Friedman,et al.  Experience with irinotecan for the treatment of malignant glioma. , 2009, Neuro-oncology.

[19]  M. J. van den Bent,et al.  Recent developments in the molecular characterization and treatment of oligodendroglial tumors. , 2003, Neuro-oncology.

[20]  M. von Knebel Doeberitz,et al.  Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. , 2005, International journal of cancer.

[21]  Wei Zhang,et al.  beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. , 2008, Cancer letters.

[22]  Lei Han,et al.  MicroRNA roles in beta-catenin pathway , 2010, Molecular Cancer.

[23]  Tao Jiang,et al.  Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription , 2010, Brain Research.

[24]  Lei Shi,et al.  MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity , 2010, Brain Research.

[25]  Y. Shoshan,et al.  Gliomas display a microRNA expression profile reminiscent of neural precursor cells. , 2010, Neuro-oncology.

[26]  Cheng He,et al.  MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme , 2009, Brain Research.

[27]  Alice Shapiro,et al.  MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. , 2008, Cancer research.

[28]  K. Somasundaram,et al.  Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma , 2010, Modern Pathology.

[29]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[30]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[31]  A. Hata,et al.  SMAD proteins control DROSHA-mediated microRNA maturation , 2008, Nature.

[32]  Xin-guo Jiang,et al.  Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. , 2010, Human gene therapy.

[33]  Mei Mei,et al.  Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status , 2010, Laboratory Investigation.

[34]  D. Frank.  STAT3 as a central mediator of neoplastic cellular transformation. , 2007, Cancer letters.

[35]  Eric C. Holland,et al.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma , 2010, Nature Reviews Cancer.

[36]  P. Wen,et al.  Antiangiogenic therapies for high-grade glioma , 2009, Nature Reviews Neurology.

[37]  J. Darnell,et al.  Stat3 Activation Is Required for Cellular Transformation by v-src , 1998, Molecular and Cellular Biology.

[38]  J. S. Rao,et al.  Molecular mechanisms of glioma invasiveness: the role of proteases , 2003, Nature Reviews Cancer.

[39]  B. Kefas,et al.  Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. , 2010, Neuro-oncology.

[40]  Anna M. Krichevsky,et al.  miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.

[41]  Ralph Weissleder,et al.  MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. , 2007, Cancer research.

[42]  T. Wurdinger,et al.  MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.